Red Tortoise LLC’s Recursion Pharmaceuticals RXRX Stock Holding History

Red Tortoise LLC’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-275	Closed	-$1.81K	–	608
2024 Q3	$1.81K	Hold	275	–	–	﹤0.01%	529
2024 Q2	$2.06K	Hold	275	–	–	﹤0.01%	507
2024 Q1	$2.74K	Hold	275	–	–	﹤0.01%	460
2023 Q4	$2.71K	Hold	275	–	–	﹤0.01%	404
2023 Q3	$2.1K	Hold	275	–	–	﹤0.01%	435
2023 Q2	$2.05K	Buy	275 +96	+54%	+$672	﹤0.01%	452
2023 Q1	$1.19K	Buy	+179	New	+$1.42K	﹤0.01%	522

Other funds holding RXRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Red Tortoise LLC's RXRX Position: Q4 2024 in Review

Red Tortoise LLC sold out of Recursion Pharmaceuticals (RXRX) in Q4 2024, closing a stake of 275 shares — an estimated $1.81K sold.

Red Tortoise LLC first reported a position in RXRX in Q1 2023 and held it in 7 quarters. The position peaked at $2.74K in Q1 2024. 316 funds tracked by Wall St. Rank hold RXRX as of Q4 2024.

Red Tortoise LLC reported no remaining Recursion Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Red Tortoise LLC sold 275 Recursion Pharmaceuticals shares in Q4 2024, an estimated $1.81K.
Red Tortoise LLC first reported a position in Recursion Pharmaceuticals in Q1 2023 and held it in 7 quarters.
Red Tortoise LLC's Recursion Pharmaceuticals position peaked at $2.74K in Q1 2024.
316 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q4 2024.

Based on Red Tortoise LLC's 13F filing for Q4 2024, filed 24 Jan 2025.